Chemed Corporation $CHE Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. lowered its stake in shares of Chemed Corporation (NYSE:CHE) by 77.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 632 shares of the company’s stock after selling 2,189 shares during the period. Vontobel Holding Ltd.’s holdings in Chemed were worth $283,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC acquired a new position in Chemed during the second quarter valued at approximately $28,000. Parkside Financial Bank & Trust lifted its stake in shares of Chemed by 86.3% during the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Allworth Financial LP lifted its position in Chemed by 20.5% during the 2nd quarter. Allworth Financial LP now owns 188 shares of the company’s stock worth $92,000 after acquiring an additional 32 shares in the last quarter. Finally, First Horizon Advisors Inc. boosted its holdings in Chemed by 16.8% in the 2nd quarter. First Horizon Advisors Inc. now owns 202 shares of the company’s stock worth $99,000 after acquiring an additional 29 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Trading Down 0.8%

Shares of CHE opened at $430.83 on Wednesday. Chemed Corporation has a 52 week low of $408.42 and a 52 week high of $623.60. The firm has a market cap of $6.10 billion, a price-to-earnings ratio of 22.78, a PEG ratio of 2.43 and a beta of 0.46. The stock has a 50 day moving average of $435.11 and a 200-day moving average of $452.34.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The firm had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. During the same quarter last year, the business earned $5.64 earnings per share. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, sell-side analysts predict that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were issued a $0.60 dividend. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is currently 12.69%.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the sale, the chief executive officer directly owned 94,197 shares in the company, valued at approximately $41,215,897.35. This represents a 2.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.29% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

CHE has been the topic of a number of analyst reports. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada cut their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Bank of America cut their price target on Chemed from $610.00 to $595.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Finally, Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and raised their price objective for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Chemed currently has a consensus rating of “Moderate Buy” and an average target price of $574.25.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.